Eva Ellebaek

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 21

Top Topics

Positron Emission Tomography

Ulcerative Colitis

Top Venues

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

BMJ open gastroenterology

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Stine K Christensen, Mette L Winther, Ida J Laursen, Freja S Madsen, Carsten Brink, Thomas H Brix, Eva Ellebaek, Inge Marie Svane, Frederikke S Hansen, Charlotte Haslund, Olivia K Laursen, Henrik Schmidt, Ida D Larsen, Lars Bastholt, Christina Halgaard Bruvik Ruhlmann
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (5) (2024)
Stine K Christensen, Mette L Winther, Ida J Laursen, Freja S Madsen, Carsten Brink, Thomas H Brix, Eva Ellebaek, Inge Marie Svane, Frederikke S Hansen, Charlotte Haslund, Olivia K Laursen, Henrik Schmidt, Ida D Larsen, Lars Bastholt, Christina Halgaard Bruvik Ruhlmann
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (5) (2024)
Stine K Christensen, Mette L Winther, Ida J Laursen, Freja S Madsen, Carsten Brink, Thomas H Brix, Eva Ellebaek, Inge Marie Svane, Frederikke S Hansen, Charlotte Haslund, Olivia K Laursen, Henrik Schmidt, Ida D Larsen, Lars Bastholt, Christina Halgaard Bruvik Ruhlmann
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (5) (2024)
Stine K Christensen, Mette L Winther, Ida J Laursen, Freja S Madsen, Carsten Brink, Thomas H Brix, Eva Ellebaek, Inge Marie Svane, Frederikke S Hansen, Charlotte Haslund, Olivia K Laursen, Henrik Schmidt, Ida D Larsen, Lars Bastholt, Christina Halgaard Bruvik Ruhlmann
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (5) (2024)
Stine K Christensen, Mette L Winther, Ida J Laursen, Freja S Madsen, Carsten Brink, Thomas H Brix, Eva Ellebaek, Inge Marie Svane, Frederikke S Hansen, Charlotte Haslund, Olivia K Laursen, Henrik Schmidt, Ida D Larsen, Lars Bastholt, Christina Halgaard Bruvik Ruhlmann
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (5) (2024)
Stine K Christensen, Mette L Winther, Ida J Laursen, Freja S Madsen, Carsten Brink, Thomas H Brix, Eva Ellebaek, Inge Marie Svane, Frederikke S Hansen, Charlotte Haslund, Olivia K Laursen, Henrik Schmidt, Ida D Larsen, Lars Bastholt, Christina Halgaard Bruvik Ruhlmann
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (5) (2024)
Sif Homburg, Charlotte Birk Christensen, Magnus Pedersen, Simon Grund Sørensen, Marco Donia, Inge Marie Svane, Helle Westergren Hendel, Eva Ellebaek
Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression. Cancers 16 (5) (2024)
Stine K Christensen, Mette L Winther, Ida J Laursen, Freja S Madsen, Carsten Brink, Thomas H Brix, Eva Ellebaek, Inge Marie Svane, Frederikke S Hansen, Charlotte Haslund, Olivia K Laursen, Henrik Schmidt, Ida D Larsen, Lars Bastholt, Christina Halgaard Bruvik Ruhlmann
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (5) (2024)
Karoline Dreyer Kattenhøj, Christine Louise Møberg, Louise Mahncke Guldbrandt, Rasmus Blechingberg Friis, Christophe Kamungu Mapendano, Søren Kjær Petersen, Christina Halgaard Bruvik Ruhlmann, Inge Marie Svane, Marco Donia, Eva Ellebaek, Henrik Schmidt
Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases-A Danish Real-World Cohort. Cancers 16 (14) (2024)
Karoline Dreyer Kattenhøj, Christine Louise Møberg, Louise Mahncke Guldbrandt, Rasmus Blechingberg Friis, Christophe Kamungu Mapendano, Søren Kjær Petersen, Christina Halgaard Bruvik Ruhlmann, Inge Marie Svane, Marco Donia, Eva Ellebaek, Henrik Schmidt
Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases-A Danish Real-World Cohort. Cancers 16 (14) (2024)
Sidsel Pedersen, Marc Østergaard Nielsen, Marco Donia, Inge Marie Svane, Bo Zerahn, Eva Ellebaek
Real-World Cardiotoxicity in Metastatic Melanoma Patients Treated with Encorafenib and Binimetinib. Cancers 16 (17) (2024)
Sif Homburg, Charlotte Birk Christensen, Magnus Pedersen, Simon Grund Sørensen, Marco Donia, Inge Marie Svane, Helle Westergren Hendel, Eva Ellebaek
Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression. Cancers 16 (5) (2024)
Karoline Dreyer Kattenhøj, Christine Louise Møberg, Louise Mahncke Guldbrandt, Rasmus Blechingberg Friis, Christophe Kamungu Mapendano, Søren Kjær Petersen, Christina Halgaard Bruvik Ruhlmann, Inge Marie Svane, Marco Donia, Eva Ellebaek, Henrik Schmidt
Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases-A Danish Real-World Cohort. Cancers 16 (14) (2024)
Stine K Christensen, Mette L Winther, Ida J Laursen, Freja S Madsen, Carsten Brink, Thomas H Brix, Eva Ellebaek, Inge Marie Svane, Frederikke S Hansen, Charlotte Haslund, Olivia K Laursen, Henrik Schmidt, Ida D Larsen, Lars Bastholt, Christina Halgaard Bruvik Ruhlmann
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (5) (2024)
Rikke Boedker Holmstroem, Emilie Kristine Dahl, Morten Helms, Henrik Vedel Nielsen, Janne Bayer Andersen, Jacob Tveiten Bjerrum, Inge Marie Svane, Eva Ellebaek, Jakob Benedict Seidelin
Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report. BMJ open gastroenterology 9 (1) (2023)
Rikke Boedker Holmstroem, Emilie Kristine Dahl, Morten Helms, Henrik Vedel Nielsen, Janne Bayer Andersen, Jacob Tveiten Bjerrum, Inge Marie Svane, Eva Ellebaek, Jakob Benedict Seidelin
Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report. BMJ open gastroenterology 9 (1) (2023)
Rikke Boedker Holmstroem, Emilie Kristine Dahl, Morten Helms, Henrik Vedel Nielsen, Janne Bayer Andersen, Jacob Tveiten Bjerrum, Inge Marie Svane, Eva Ellebaek, Jakob Benedict Seidelin
Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report. BMJ open gastroenterology 9 (1) (2023)
Eva Ellebaek, Aimilia Schina, Rikke Andersen, Helle Westergren Hendel, Inge Marie Svane, Marco Donia
Clinical value of routine [18F]2-fluoro-2-deoxy-d-glucose positron emission tomography scans as a decision tool for early immunotherapy discontinuation in advanced melanoma. International journal of cancer 150 (11) (2022)
Sidsel Pedersen, Kirstine Ostenfeld Larsen, Alex Hørby Christensen, Inge Marie Svane, Bo Zerahn, Eva Ellebaek
Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting. Acta oncologica (Stockholm, Sweden) (2021)
Julie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Evelina Martinenaite, Eva Ellebaek, Marco Donia, Rikke Boedker Holmstroem, Tobias Wirenfeldt Klausen, Cecilie Oelvang Madsen, Shamaila Munir Ahmed, Stine Emilie Weis-Banke, Morten Orebo Holmström, Helle Westergren Hendel, Eva Ehrnrooth, Mai-Britt Zocca, Ayako Wakatsuki Pedersen, Mads Hald Andersen, Inge Marie Svane
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma. Nature medicine (2021)
Morten Fink, Anders Schwartz Vittrup, Lars Bastholt, Inge Marie Svane, Marco Donia, Adam A Luczak, Christina Halgaard Bruvik Ruhlmann, Louise Mahncke Guldbrandt, Ulrich Heide Koehler, Mette Lerche Winther, Eva Ellebaek, Charlotte Aaquist Haslund, Henrik Schmidt
Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study. Cancers 13 (21) (2021)